Apoptosis and cell proliferation after porcine coronary angioplasty.
BACKGROUND
Angioplasty initiates a number of responses in the vessel wall including cellular migration, proliferation, and matrix accumulation, all of which contribute to neointima formation and restenosis. Cellular homeostasis within a tissue depends on the balance between cell proliferation and apoptosis.


RESULTS
Profiles of apoptosis and proliferation were therefore examined in a porcine PTCA injury model over a 28-day period. Forty-two arteries from 21 pigs, harvested at the site of maximal injury at 1, 6, and 18 hours, and 3, 7, 14, and 28 days after PTCA, were examined (n=3 animals per time point). Uninjured arteries were used as controls. Apoptosis was demonstrated by the terminal uridine nick-end labeling (TUNEL) method, transmission electron microscopy (TEM), and DNA fragmentation. Cells traversing the cell cycle were identified by immunostaining for proliferating cell nuclear antigen (PCNA). Apoptosis was not detected in control vessels at all time points nor at 28 days after PTCA. Apoptotic cells were identified at all early time points with a peak at 6 hours (5.1+/-0.26%; compared to uninjured artery, P<0.001) and confirmed by characteristic DNA ladders and TEM findings. Regional analysis showed apoptosis within the media, adventitia, and neointima peaked at 18 hours, 6 hours, and 7 days after PTCA, respectively. In comparison, PCNA staining peaked at 3 days after PTCA (7.16+/-0.29%; compared to 1.78+/-0.08% PCNA-positive cells in the uninjured artery, P<0.001). Profiles of apoptosis and cell proliferation after PTCA were discordant in all layers of the artery except the neointima. These profiles also differed between traumatized and nontraumatized regions of the arterial wall. Immunostaining with cell-type specific markers and TEM analysis revealed that apoptotic cells included vascular smooth muscle cells (VSMCs), inflammatory cells, and adventitial fibroblasts.


CONCLUSIONS
These results suggest that the profile of apoptosis and proliferation after PTCA is regional and cell specific, and attempts to modulate either of these events for therapeutic benefit requires recognition of these differences.
Malik
N
N
Sections of Cardiology and Interventional Cardiology, University of Sheffield, Clinical Sciences Centre, Northern General Hospital, Sheffield, UK. n.malik@sheffield.ac.uk
Francis
S E
SE
Holt
C M
CM
Gunn
J
J
Thomas
G L
GL
Shepherd
L
L
Chamberlain
J
J
Newman
C M
CM
Cumberland
D C
DC
Crossman
D C
DC
D000199:Actins / Q000032:analysis; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000818:Animals; D000941:Antigens / Q000032:analysis; D017209:Apoptosis / Q000502:physiology*; D002455:Cell Division / Q000502:physiology; D002467:Cell Nucleus / Q000648:ultrastructure; D003331:Coronary Vessels / Q000293:injuries*; D020287:In Situ Nick-End Labeling; D016015:Logistic Models; D008854:Microscopy, Electron; D009131:Muscle, Smooth, Vascular / Q000276:immunology / Q000648:ultrastructure; D013194:Staining and Labeling; D013552:Swine
D000199:Actins; D000941:Antigens